Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Taxes (2020 - 2023)

Historic Change in Taxes for Oncology Institute (TOI) over the last 4 years, with Q4 2023 value amounting to -$255000.0.

  • Oncology Institute's Change in Taxes fell 9318.18% to -$255000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$133000.0, marking a year-over-year decrease of 20813.01%. This contributed to the annual value of -$255000.0 for FY2023, which is 30731.71% down from last year.
  • Per Oncology Institute's latest filing, its Change in Taxes stood at -$255000.0 for Q4 2023, which was down 9318.18% from -$1000.0 recorded in Q3 2023.
  • In the past 5 years, Oncology Institute's Change in Taxes ranged from a high of $4.4 million in Q3 2021 and a low of -$6.0 million during Q4 2021
  • Over the past 4 years, Oncology Institute's median Change in Taxes value was $50025.0 (recorded in 2020), while the average stood at -$40833.3.
  • The largest annual percentage gain for Oncology Institute's Change in Taxes in the last 5 years was 866200.0% (2021), contrasted with its biggest fall of 129181.33% (2021).
  • Oncology Institute's Change in Taxes (Quarter) stood at $505700.0 in 2020, then crashed by 1291.81% to -$6.0 million in 2021, then surged by 97.81% to -$132000.0 in 2022, then crashed by 93.18% to -$255000.0 in 2023.
  • Its Change in Taxes was -$255000.0 in Q4 2023, compared to -$1000.0 in Q3 2023 and -$132000.0 in Q4 2022.